Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
F756 in Louisiana. Pick another state for the same tag.
Against expectation — 2025
Louisiana cites F756 less often than its own record predicts
Versus expected share0.48×
0.48 times the national share — cited less often here than elsewhere.
Share of Louisiana citations0.38%
Of every deficiency written in Louisiana in 2025, this is the portion that was F756.
Louisiana0.38%
National0.79%
Share of all citations that were F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Louisiana surveyors wrote
F756 findings written in Louisiana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedAugust 13, 2026
Based on record reviews and interviews, the pharmacist failed to identify and report irregularities to the attending physician, the facility's medical director, and director of nursing for 1 (#73) of 5 residents reviewed for unnecessary medications.Findings:Review of the record for Resident #73 revealed an admission date of 11/03/2025 with diagnoses that included type 2 diabetes mellitus, insomnia, unspecified mood disorder, cerebrovascular disease, edema, hypertension, depression, and seizure disorder.Review of the quarterly MDS assessment dated [DATE] revealed a BIMS score of 15 which indicated she was cognitively intact with daily decision making. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction